1. Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?. (1st February 2022) Authors: Mayr, Christian; Kiesslich, Tobias; Modest, Dominik Paul; Stintzing, Sebastian; Ocker, Matthias; Neureiter, Daniel Journal: Expert opinion on investigational drugs Issue: Volume 31:Number 2(2022) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clonality and timing of relapsing colorectal cancer metastasis revealed through whole-genome single-cell sequencing. (1st September 2022) Authors: Alves, Joao M.; Prado-López, Sonia; Tomás, Laura; Valecha, Monica; Estévez-Gómez, Nuria; Alvariño, Pilar; Geisel, Dominik; Modest, Dominik Paul; Sauer, Igor M.; Pratschke, Johann; Raschzok, Nathanael; Sers, Christine; Mamlouk, Soulafa; Posada, David Journal: Cancer letters Issue: Volume 543(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases – The PARLIM trial (AIO KRK 0314). (September 2022) Authors: Modest, Dominik Paul; Karthaus, Meinolf; Kasper, Stefan; Moosmann, Nicolas; Keitel, Verena; Kiani, Alexander; Uhlig, Jens; Jacobasch, Lutz; Fischer v. Weikersthal, Ludwig; Fuchs, Martin; Kaiser, Florian; Lerchenmüller, Christian; Sent, Dagmar; Junghanß, Christian; Held, Swantje; Lorenzen, Sylvie;... Journal: European journal of cancer Issue: Volume 173(2022) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer. (July 2015) Authors: Camaj, Peter; Primo, Stefano; Wang, Yan; Heinemann, Volker; Zhao, Yue; Laubender, Ruediger Paul; Stintzing, Sebastian; Giessen-Jung, Clemens; Jung, Andreas; Gamba, Sebastian; Bruns, Christiane Josephine; Modest, Dominik Paul Journal: Future oncology Issue: Volume 11:Number 13(2015) Page Start: 1919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma—Very good response predominantly in patients with intestinal type tumors. Issue 3 (25th February 2015) Authors: Schulz, Christoph; Kullmann, Frank; Kunzmann, Volker; Fuchs, Martin; Geissler, Michael; Vehling‐Kaiser, Ursula; Stauder, Heribert; Wein, Axel; Al‐Batran, Salah‐Eddin; Kubin, Thomas; Schäfer, Claus; Stintzing, Sebastian; Giessen, Clemens; Modest, Dominik Paul; Ridwelski, Karsten; Heinemann, Volker Journal: International journal of cancer Issue: Volume 137:Issue 3(2015:Aug. 01) Page Start: 678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212). Issue 1 (1st January 2022) Authors: Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Jarosch, Armin; Horst, David; R... Journal: Journal of clinical oncology Issue: Volume 40:Issue 1(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Panitumumab‐based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials. Issue 2 (24th January 2019) Authors: Modest, Dominik Paul; Rivera, Fernando; Bachet, Jean‐Baptiste; de Braud, Filippo; Pietrantonio, Filippo; Koukakis, Reija; Demonty, Gaston; Douillard, Jean‐Yves Journal: International journal of cancer Issue: Volume 145:Issue 2(2019) Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Predictors of EGF receptor monoclonal antibody activity in metastatic colorectal cancer: current status. (October 2012) Authors: Modest, Dominik Paul; Giessen, Clemens; Stintzing, Sebastian Journal: Colorectal cancer Issue: Volume 1:Number 5(2012) Page Start: 423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: Results from a randomized trial of the GERMAN AIO CRC Study Group. Issue 1 (26th June 2012) Authors: Stintzing, Sebastian; Kapaun, Christine; Laubender, Rüdiger Paul; Jung, Andreas; Neumann, Jens; Modest, Dominik Paul; Giessen, Clemens; Moosmann, Nicolas; Wollenberg, Andreas; Kirchner, Thomas; Heinemann, Volker Journal: International journal of cancer Issue: Volume 132:Issue 1(2013:Jan. 01) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Relevance of liver‐limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE‐3/AIO KRK0306 trial. Issue 5 (7th November 2017) Authors: Holch, Julian Walter; Ricard, Ingrid; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling‐Kaiser, Ursula; Al‐Batran, Salah‐Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Scholz, Michael; Müller... Journal: International journal of cancer Issue: Volume 142:Issue 5(2018) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗